Anavex Life Sciences
AVXL
78 hedge funds and large institutions have $57.7M invested in Anavex Life Sciences in 2020 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 24 increasing their positions, 22 reducing their positions, and 10 closing their positions.
10% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 10
1% more funds holding
Funds holding: 77 → 78 (+1)
9% more repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 22
0.71% more ownership
Funds ownership: 20.36% → 21.08% (+0.71%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
2% less capital invested
Capital invested by funds: $58.8M → $57.7M (-$1.14M)
56% less call options, than puts
Call options by funds: $760K | Put options by funds: $1.72M
Top Buyers
Top Sellers
| 1 |
Invesco
Atlanta,
Georgia
|
-$654K |
| 2 |
KCM
Knoll Capital Management
Miami,
Florida
|
-$445K |
| 3 |
BlackRock
New York
|
-$176K |
| 4 |
Group One Trading
Chicago,
Illinois
|
-$154K |
| 5 |
D.E. Shaw & Co
New York
|
-$153K |
AVXL Hedge Fund Activity: Q3 2020 in Review
78 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Anavex Life Sciences (AVXL) for Q3 2020, worth a combined $57.7M — down 1.9% from $58.8M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new AVXL positions and 10 closed out — a net gain of 1 holder — while 24 added to existing stakes and 22 trimmed.
The largest buyer was Russell Investments Group, adding an estimated $1.19M. The largest seller was Invesco, exiting entirely with an estimated $654K sold.
- 78 institutional investors held Anavex Life Sciences (AVXL) as of Q3 2020, up from 77 in Q2 2020.
- Funds reported $57.7M of Anavex Life Sciences stock for Q3 2020, down 1.9% quarter-over-quarter.
- 11 funds opened new Anavex Life Sciences positions in Q3 2020 and 10 closed out, a net change of +1 holder.
- The largest Anavex Life Sciences buyer in Q3 2020 was Russell Investments Group, an estimated $1.19M added.
- The largest Anavex Life Sciences seller in Q3 2020 was Invesco, an estimated $654K sold.
Based on aggregated 13F filings for Q3 2020.